Hustings, Nico http://orcid.org/0000-0002-1805-6315
Thonissen, Yannick http://orcid.org/0000-0002-9267-7208
Cockmartin, Lesley http://orcid.org/0000-0003-2449-5872
Vanderseypen, Koen
Baldewijns, Marcella http://orcid.org/0000-0002-0882-2944
De Catte, Luc http://orcid.org/0000-0002-5287-9673
Thal, Dietmar Rudolf http://orcid.org/0000-0002-1036-1075
Aertsen, Michael http://orcid.org/0000-0003-1994-5365
Article History
Received: 1 September 2022
Revised: 20 September 2022
Accepted: 1 December 2022
First Online: 29 December 2022
Declarations
:
: Author D.R.T. received speaker honorarium from Novartis Pharma Basel (Switzerland) and Biogen (USA), travel reimbursement from GE Healthcare (UK), and UCB (Belgium), and collaborated with GE Healthcare (UK), Novartis Pharma Basel (Switzerland), Probiodrug (Germany), and Janssen Pharmaceutical Companies (Belgium). Author D.R.T. also receives funding from FWO (G0F8516N, G065721N) and SAO/FRA (2020/017). The other authors declare no conflicts of interest.